Ovarian cancer
Last updated 8 May 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Ovarian cancer is a disease that affects women. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumour. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.
Video picks for Genetic conditionsVideo library
Description
Ovarian cancer is a disease that affects women. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumour. The ovaries are the female reproductive organs in which egg cells are produced. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.
The most common form of ovarian cancer begins in epithelial cells, which are the cells that line the surfaces and cavities of the body. These cancers can arise in the epithelial cells on the surface of the ovary. However, researchers suggest that many or even most ovarian cancers begin in epithelial cells on the fringes (fimbriae) at the end of one of the fallopian tubes, and the cancerous cells migrate to the ovary.
Cancer can also begin in epithelial cells that form the lining of the abdomen (the peritoneum). This form of cancer, called primary peritoneal cancer, resembles epithelial ovarian cancer in its origin, symptoms, progression, and treatment. Primary peritoneal cancer often spreads to the ovaries. It can also occur even if the ovaries have been removed. Because cancers that begin in the ovaries, fallopian tubes, and peritoneum are so similar and spread easily from one of these structures to the others, they are often difficult to distinguish. These cancers are so closely related that they are generally considered collectively by experts.
In about 10 percent of cases, ovarian cancer develops not in epithelial cells but in germ cells, which are precursors to egg cells, or in hormone-producing ovarian cells called granulosa cells.
In its early stages, ovarian cancer usually does not cause noticeable symptoms. As the cancer progresses, signs and symptoms can include pain or a feeling of heaviness in the pelvis or lower abdomen, bloating, feeling full quickly when eating, back pain, vaginal bleeding between menstrual periods or after menopause, or changes in urinary or bowel habits. However, these changes can occur as part of many different conditions. Having one or more of these symptoms does not mean that a woman has ovarian cancer.
In some cases, cancerous tumours can invade surrounding tissue and spread to other parts of the body. If ovarian cancer spreads, cancerous tumours most often appear in the abdominal cavity or on the surfaces of nearby organs such as the bladder or colon. Tumours that begin at one site and then spread to other areas of the body are called metastatic cancers.
Some ovarian cancers cluster in families. These cancers are described as hereditary and are associated with inherited gene mutations. Hereditary ovarian cancers tend to develop earlier in life than non-inherited (sporadic) cases.
Because it is often diagnosed at a late stage, ovarian cancer can be difficult to treat; it leads to the deaths of about 14,000 women annually in the United States, more than any other gynecological cancer. However, when it is diagnosed and treated early, the 5-year survival rate is high.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown; Not inherited; Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Cancer of the ovary
Malignant neoplasm of the ovary
Malignant tumour of the ovary
Ovarian carcinoma
Patient picks for Genetic conditions

Cancer
Ovarian cancer
Ovarian cancer is the sixth most common cancer in women in the UK. It is more common than cancer of the neck of the womb (cervical cancer).
by Dr Hayley Willacy, FRCGP

Cancer
Ovarian cancer symptoms diary
The ovarian cancer symptoms diary has been produced by Target Ovarian Cancer. This is a national ovarian cancer charity. It works to save lives and help women diagnosed with the condition live their lives to the full.
by Patient clinician team

Cancer
Do you know the early signs of ovarian cancer?
Just one in five women realise bloating is a symptom of ovarian cancer. Early diagnosis makes the disease easier to treat, so it's important to be aware of the signs.
by Amberley Davis

Cancer
How my Ovarian Cancer was missed: Natasha tells her story
Across the UK, thousands of women each year are only diagnosed with ovarian cancer once they reach emergency care. Among them is Natasha Reynolds, who was just 22 when she began noticing the first signs of the disease. Despite repeatedly seeking help, her concerns were dismissed, even as her symptoms worsened. It was only after she sought emergency care that she finally received a diagnosis - stage one germ cell ovarian cancer, an extremely rare form of the disease that primarily affects young people. Natasha’s story is a powerful reminder of the importance of taking women’s symptoms seriously and of how many lives could be saved through earlier detection of ovarian cancer.
by Victoria Raw

Cancer
Spotting the signs of ovarian cancer: why acting early matters
In the UK, thousands of women are diagnosed with ovarian cancer only after reaching emergency care. Alarmingly, just one in three cases is identified at the earliest stages - when treatment is most effective. We sat down with Jo Stanford, Health Projects Manager and spokesperson for Ovarian Cancer Action, to discuss why so many women are still diagnosed late, the symptoms that should raise concern, and the steps to take if something doesn’t feel right.
by Victoria Raw

Health news
Ovarian cancer drug approved for NHS use will prolong lives
A drug that can treat chemotherapy-resistant ovarian cancer has just been approved for use on the NHS in England. Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.
by Professor Steve Conlan
Related patient information and medicines

Patient information leaflet
Ovarian cancer
Ovarian cancer is the sixth most common cancer in women in the UK. It is more common than cancer of the neck of the womb (cervical cancer). Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info Ovarian cancer is the sixth most common... They are classified by the type of cell from which the cancer originates: Epithelial ovarian cancer This.

Patient information leaflet
Ovarian cyst
Ovarian cysts are fluid-filled pockets that grow on the ovaries. Almost all ovarian cysts are non-cancerous (benign), but some are cancerous (malignant), or may b... Ovarian cancer Ovarian cancer is a rare cause of ovarian cysts. Exactly why cancer develops is very complicated, and not fully understood. We do know, though, that cancer cells.

Patient information leaflet
BRCA genes
The BRCA1 and BRCA2 genes normally protect against certain cancers, particularly breast ca... The estimated lifetime risk of ovarian cancer is 40-63 in 100. The estimated lifetime risk of ovarian cancer is 10-27 in 100. Ovarian cancer About 1 in 100 women will develop ovarian cancer sometime during their lives. However, more than 90 in 100 of.

Patient information leaflet
Children's cancers
Childhood cancer is rare and is much less common than cancer in adults. There are many different type of cancer that can affect childr... It can also cause bone pain and swelling. They are mainly found in the ovary or testicle. They can also very rarely occur in other parts of the body. See also the separate leaflets called Testicular Cancer.

Patient information leaflet
Gynaecological cancer
A number of cancers can arise in the female reproductive organs. This leaflet explains where these organs are and links to information about the individual cancers. Cancer of the ovary Ovarian cancer. Studies have been done to look into whether ovarian cancer screening might be pos... The biggest study, looking at scans and blood tests, ended in.

Patient information leaflet
Breast cancer facts and risk factors
Dr Sarah Jarvis MBE Although breast cancer can develop for no apparent reason, there are certain risk factors which increase the... If you carry one or more of these mutations you have an increased risk of developing breast cancer (and certain other cancers such as ovarian cancer). If both breast and ovarian cancer run in the family. If certain.
Further reading and references
- Ovarian cancer; MedlinePlus, National Library of Medicine.
- Dietl J. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet. 2014 Feb;289(2):241-6. doi: 10.1007/s00404-013-3041-3. Epub 2013 Oct 8.
- Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014 Oct 11;384(9951):1376-88. doi: 10.1016/S0140-6736(13)62146-7. Epub 2014 Apr 21.
- Kim YM, Lee SW, Chun SM, Kim DY, Kim JH, Kim KR, Kim YT, Nam JH, van Hummelen P, MacConaill LE, Hahn WC, Jang SJ. Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples. PLoS One. 2014 Jun 17;9(6):e99451. doi: 10.1371/journal.pone.0099451. eCollection 2014.
- Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. Epub 2013 Jun 19.
- Pennington KP, Swisher EM. Hereditary ovarian cancer: beyond the usual suspects. Gynecol Oncol. 2012 Feb;124(2):347-53. doi: 10.1016/j.ygyno.2011.12.415.
- Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. J Obstet Gynaecol Can. 2014 Feb;36(2):133-140. doi: 10.1016/S1701-2163(15)30659-9.
- Shulman LP. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome. Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
- Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L. Hereditary ovarian cancer: not only BRCA 1 and 2 genes. Biomed Res Int. 2015;2015:341723. doi: 10.1155/2015/341723. Epub 2015 May 17.
- Weissman SM, Weiss SM, Newlin AC. Genetic testing by cancer site: ovary. Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

